Cognitive Load and Inhaler Technique in COPD (DUAL-INH)
25 de agosto de 2026 actualizado por: Crisan Alexandru Florian, Spitalul Clinic de Boli Infecțioase și Pneumoftiziologie Dr. Victor Babeș Timișoara
Cognitive Load-Induced Inhaler Errors in COPD: Linking Dual-Task Mobility to Treatment Self-Management
This study evaluates whether cognitive load affects inhaler technique in adults with chronic obstructive pulmonary disease (COPD).
During a single study visit, participants will complete assessments of cognitive function, mobility, and respiratory status.
Dual-task mobility will be assessed using the Timed Up and Go test performed alone and while completing a cognitive task.
Inhaler technique will then be evaluated in two conditions: usual inhaler use without an additional task and inhaler use while maintaining a short sequence of digits in working memory.
Inhaler technique will be scored using a standardized five-step device-specific checklist, and inhaler use time will also be recorded.
The study will examine whether inhaler technique worsens under cognitive load and whether this deterioration is associated with dual-task mobility performance, cognitive function, respiratory symptoms, and functional capacity.
No inhaler training or correction will be provided between the two inhaler conditions.
All assessments are performed during a single visit.
Descripción general del estudio
Estado
Reclutamiento
Condiciones
Intervención / Tratamiento
Tipo de estudio
Intervencionista
Inscripción (Estimado)
100
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Estudio Contacto
- Nombre: Alexandru Crișan
- Número de teléfono: 0765525688
- Correo electrónico: crisan@umft.ro
Ubicaciones de estudio
-
-
Timiș County
-
Timișoara, Timiș County, Rumania, 300041
- Reclutamiento
- "Dr. Victor Babeș" Clinical Hospital of Infectious Diseases and Pneumophthisiology, Timișoara
-
Contacto:
- Alexandru Crișan
- Número de teléfono: 0765525688
- Correo electrónico: crisan@umft.ro
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
No
Descripción
Inclusion Criteria:
- Adults aged 18 years or older
- Confirmed diagnosis of chronic obstructive pulmonary disease (COPD)
- Clinically stable at the time of assessment
- Current use of at least one handheld maintenance inhaler (pMDI, SMI, or DPI)
- Able to understand and follow study instructions
- Able to perform the Timed Up and Go test
- Able to complete the cognitive tasks and inhaler technique assessment
- Able and willing to provide written informed consent
Exclusion Criteria:
- Recent COPD exacerbation with incomplete recovery to baseline clinical status
- Acute respiratory or other acute medical condition at the time of assessment
- Known severe cognitive impairment or dementia that prevents completion of study procedures
- Neurological or musculoskeletal impairment that prevents safe completion of the Timed Up and Go test
- Severe visual, hearing, or communication impairment that prevents completion of the cognitive or inhaler tasks
- Inability to independently handle or use the study inhaler device for assessment purposes
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Otro
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación cruzada
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Single-Task Followed by Cognitive Dual-Task
Participants first perform inhaler use under the single-task condition, without a concurrent cognitive task.
After a short rest and without any inhaler-technique training or correction, they perform inhaler use under a working-memory cognitive load.
In both conditions, inhaler technique is scored using the same standardized five-item device-specific checklist and inhaler-use time is recorded.
|
Participants are presented with a standardized five-digit sequence before inhaler use and are instructed to retain the sequence in working memory while completing their usual inhaler technique.
The sequence is presented once at approximately one digit per second.
Participants do not verbalize the digits during inhaler use.
Immediately after completing the inhaler maneuver, they reproduce the sequence in reverse order.
Inhaler technique is simultaneously assessed using a standardized five-item device-specific checklist, and inhaler-use time is recorded.
Participants use their usual maintenance inhaler without a concurrent cognitive task.
They are instructed to use the inhaler as they normally do at home.
Inhaler technique is assessed using the same standardized five-item device-specific checklist, and inhaler-use time is recorded.
No inhaler-technique training, correction, or feedback is provided before completion of both study conditions.
|
|
Experimental: Cognitive Dual-Task Followed by Single-Task
Participants first perform inhaler use under a working-memory cognitive load.
After a short rest and without any inhaler-technique training or correction, they perform inhaler use under the single-task condition without a concurrent cognitive task.
In both conditions, inhaler technique is scored using the same standardized five-item device-specific checklist and inhaler-use time is recorded.
|
Participants are presented with a standardized five-digit sequence before inhaler use and are instructed to retain the sequence in working memory while completing their usual inhaler technique.
The sequence is presented once at approximately one digit per second.
Participants do not verbalize the digits during inhaler use.
Immediately after completing the inhaler maneuver, they reproduce the sequence in reverse order.
Inhaler technique is simultaneously assessed using a standardized five-item device-specific checklist, and inhaler-use time is recorded.
Participants use their usual maintenance inhaler without a concurrent cognitive task.
They are instructed to use the inhaler as they normally do at home.
Inhaler technique is assessed using the same standardized five-item device-specific checklist, and inhaler-use time is recorded.
No inhaler-technique training, correction, or feedback is provided before completion of both study conditions.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Inhaler Technique Performance Under Cognitive Load
Periodo de tiempo: During the single study visit, immediately after completion of both inhaler conditions
|
Difference in the number of satisfactory inhaler-technique steps between the cognitive dual-task condition and the single-task condition, assessed using the same standardized 5-item device-specific inhaler technique checklist.
Each checklist item is scored as 1 = satisfactory or 0 = unsatisfactory/omitted, yielding a total score of 0 to 5 for each condition.
The primary outcome is calculated as dual-task satisfactory score minus single-task satisfactory score, with a possible range from -5 to +5.
Negative values indicate deterioration of inhaler technique under cognitive load.
|
During the single study visit, immediately after completion of both inhaler conditions
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
New Inhaler Error Under Cognitive Load
Periodo de tiempo: During the single study visit, immediately after completion of both inhaler conditions
|
Binary outcome indicating whether inhaler technique deteriorates under cognitive load.
A new inhaler error is defined as having fewer satisfactory items on the standardized 5-item inhaler technique checklist during the cognitive dual-task condition than during the single-task condition.
Coded as 1 = deterioration under cognitive load and 0 = no deterioration.
|
During the single study visit, immediately after completion of both inhaler conditions
|
|
Worsening of Inhaler Technique Classification Under Cognitive Load
Periodo de tiempo: During the single study visit, immediately after completion of both inhaler conditions
|
Binary outcome indicating whether the participant's inhaler technique classification worsens from Acceptable during the single-task condition to Unacceptable during the cognitive dual-task condition.
Inhaler technique is classified using the standardized 5-item checklist, with 4-5 satisfactory steps classified as Acceptable and 0-3 satisfactory steps classified as Unacceptable.
Coded as 1 = classification worsened and 0 = no worsening.
|
During the single study visit, immediately after completion of both inhaler conditions
|
|
Inhaler Time Dual-Task Cost
Periodo de tiempo: During the single study visit, immediately after completion of both inhaler conditions
|
Percentage change in inhaler-use time between the cognitive dual-task and single-task conditions.
It is calculated as [(dual-task inhaler time - single-task inhaler time) / single-task inhaler time] × 100.
Positive values indicate slower inhaler use under cognitive load.
|
During the single study visit, immediately after completion of both inhaler conditions
|
|
Inhaler Cognitive Dual-Task Cost
Periodo de tiempo: During the single study visit, immediately after completion of the inhaler cognitive assessments
|
Percentage change in working-memory performance between the cognitive single-task condition and the inhaler cognitive dual-task condition.
It is calculated as [(single-task cognitive accuracy - dual-task cognitive accuracy) / single-task cognitive accuracy] × 100.
Positive values indicate poorer cognitive performance while using the inhaler under cognitive load.
|
During the single study visit, immediately after completion of the inhaler cognitive assessments
|
|
Physical Dual-Task Cost During Timed Up and Go
Periodo de tiempo: During the single study visit, immediately after completion of the single-task and dual-task Timed Up and Go assessments
|
Percentage increase in Timed Up and Go completion time during the cognitive dual-task condition compared with the single-task condition.
It is calculated as [(TUG dual-task time - TUG single-task time) / TUG single-task time] × 100.
Positive values indicate slower mobility performance during dual-tasking.
|
During the single study visit, immediately after completion of the single-task and dual-task Timed Up and Go assessments
|
|
Cognitive Dual-Task Cost During Timed Up and Go
Periodo de tiempo: During the single study visit, immediately after completion of the cognitive single-task and dual-task Timed Up and Go assessments
|
Percentage reduction in cognitive performance during the dual-task Timed Up and Go condition compared with the cognitive single-task condition.
Cognitive performance is quantified using the rate of correct responses per second.
The outcome is calculated as [(single-task correct-response rate - dual-task correct-response rate) / single-task correct-response rate] × 100.
Positive values indicate poorer cognitive performance during dual-task walking.
|
During the single study visit, immediately after completion of the cognitive single-task and dual-task Timed Up and Go assessments
|
|
Change in Inhaler Completion Time Under Cognitive Load
Periodo de tiempo: During the single study visit, immediately after completion of both inhaler conditions
|
Absolute difference in inhaler-use time between the cognitive dual-task and single-task conditions.
It is calculated as dual-task inhaler time minus single-task inhaler time, expressed in seconds.
Positive values indicate longer inhaler-use time under cognitive load.
|
During the single study visit, immediately after completion of both inhaler conditions
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
21 de agosto de 2026
Finalización primaria (Estimado)
30 de septiembre de 2027
Finalización del estudio (Estimado)
30 de noviembre de 2027
Fechas de registro del estudio
Enviado por primera vez
21 de agosto de 2026
Primero enviado que cumplió con los criterios de control de calidad
21 de agosto de 2026
Publicado por primera vez (Actual)
25 de agosto de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
26 de agosto de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
25 de agosto de 2026
Última verificación
1 de agosto de 2026
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- COPD-DT-INHALER-2026-01
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
NO
Descripción del plan IPD
Individual participant data will not be made publicly available.
De-identified data may be provided by the corresponding investigator upon reasonable request, subject to approval by the study team and, where required, the relevant ethics committee and institutional data-protection requirements.
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .